Latest filing published 06 Apr 2020 for Stagecoach Group plc, €269.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Ross Paterson: trading record in brief
All filings by Ross Paterson on record concern Stagecoach Group plc. We count 40 filings; the first trade dates from 28 June 2016 and the latest from 1 April 2020.
Purchases make up the whole of the open-market record (1 purchase, €17k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 39 share grants.
Most recently, on 6 April 2020, the filings show a share grant worth €269 in Stagecoach Group plc. The last insider purchase was made public on 29 June 2017, 3,419 days ago. The median gap between a trade and its publication by RNS (LSE) is 1 day. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Ross Paterson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 238 shares@ £0.6281XLONISIN GB00B6YTLS95FCA-NSM:1000329601-en-1
- 292 shares@ £1.078169.5% of flowXLONISIN GB00B6YTLS95FCA-NSM:NASDAQ_1000324267-en_20200331164956970_14698-1
- 124 shares@ £1.206530.5% of flowXLONISIN GB00B6YTLS95FCA-NSM:NASDAQ_1000316839-en_20200331164939226_3105-1
- 105 shares@ £1.4278XLONISIN GB00B6YTLS95FCA-NSM:NASDAQ_1000311873-en_20200331164951283_2591-1
- 126 shares@ £1.1911XLONISIN GB00B6YTLS95FCA-NSM:NASDAQ_1000297190-en_20200326185106301_28002-1
- 123 shares@ £1.21890.7% of flowXLONISIN GB00B6YTLS95FCA-NSM:NASDAQ_1000291632-en_20200326185148649_29558-1
- 219 shares@ £1.321524.0% of flowXLONISIN GB00B6YTLS95FCA-NSM:NASDAQ_1000287458-en_20200326185154444_24749-1
- 124 shares@ £1.211713.8% of flowXLONISIN GB00B6YTLS95FCA-NSM:NASDAQ_1000276213-en_20200326185156105_33489-1
- 137 shares@ £1.099414.9% of flowXLONISIN GB00B6YTLS95FCA-NSM:NASDAQ_1000261003-en_20200326185205209_38192-1
- 127 shares@ £1.17920.6% of flowXLONISIN GB00B6YTLS95FCA-NSM:NASDAQ_1000255370-en_20200326185059888_40485-1
- 138 shares@ £1.08310.7% of flowXLONISIN GB00B6YTLS95FCA-NSM:NASDAQ_1000230463-en_20200326185125271_35958-1
- 30,496 sharesOutside a trading venueISIN GB00B6YTLS95FCA-NSM:NASDAQ_1000230421-en_20200326185125283_36227-1
- 233,516 sharesOutside a trading venueISIN GB00B6YTLS95FCA-NSM:NASDAQ_1000219836-en_20200326185128335_872-1
- 134 shares@ £1.127.7% of flowXLONISIN GB00B6YTLS95FCA-NSM:NASDAQ_1000196267-en_20200326185130095_29219-1
- 127 shares@ £1.17887.5% of flowXLONISIN GB00B6YTLS95FCA-NSM:NASDAQ_1000190817-en_20200326185143141_27572-1
- 110 shares@ £1.36810.6% of flowXLONISIN GB00B6YTLS95FCA-NSM:NASDAQ_1000175847-en_20200326185045040_23757-1
- 149 shares@ £1.6310.8% of flowXLONISIN GB00B6YTLS95FCA-NSM:NASDAQ_1000153236-en_20200326185133713_11790-1
- 104 shares@ £1.44130.6% of flowXLONISIN GB00B6YTLS95FCA-NSM:NASDAQ_1000151107-en_20200326185134434_26888-1
- 109 shares@ £1.38096.3% of flowXLONISIN GB00B6YTLS95FCA-NSM:NASDAQ_1000146997-en_20200326185112579_23757-1
- 124 shares@ £1.20337.0% of flowXLONISIN GB00B6YTLS95FCA-NSM:NASDAQ_1000142772-en_20200326185119381_27838-1
- 150,518 sharesOutside a trading venueISIN GB00B6YTLS95FCA-NSM:NASDAQ_1000139409-en_20200330111408046_5809-1
- 109 shares@ £1.38716.2% of flowXLONISIN GB00B6YTLS95FCA-NSM:NASDAQ_1000138969-en_20200330111407831_1628-1
- 107 shares@ £1.39330.6% of flowXLONISIN GB00B6YTLS95FCA-NSM:NASDAQ_1000104912-en_20200330111439167_29378-1
- 143 shares@ £1.5650.8% of flowXLONISIN GB00B6YTLS95FCA-NSM:NASDAQ_1000101954-en_20200330111443489_19998-1
- 105 shares@ £1.42560.6% of flowXLONISIN GB00B6YTLS95FCA-NSM:NASDAQ_1000101141-en_20200330111443818_27026-1
25 of 40 declarations